The International Pregnancy Safety Study (InPreSS) Consortium
The International Pregnancy Safety Study (InPreSS) Consortium is a collaboration among research groups with access to health care databases with demonstrated ability to study the safety of medications in pregnancy: nationwide Medicaid data that cover close to 50% of pregnancies in the US, and the national registries in the five Nordic countries that cover virtually all pregnancies resulting in live births or stillbirths in these countries.
Members
Mette Norgaard, MD, PhD | Research Assistant Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, Denmark
Mika Gissler, PhD | Information Services Department, THLNational Institute for Health and Welfare, Helsinki, Finland | Research Centre for Child Psychiatry, University of Turku, Turku, Finland
Department of Neurobiology, Care Sciences and Society, Division of Family Medicine, Karolinska Institutet, Stockholm, Sweden
Helga Zoega, MA, PhD | Centre of Public Health Sciences, Faculty of Medicine, University of Iceland, Reykjavik, Iceland
Medicines Policy Research Unit, Centre for Big Data Research in Health, UNSW, Sydney, New South Wales, Australia
Kari Furu, MScPharm, MPH, PhD | Department of Pharmacoepidemiology, Norwegian Institute of Public Health, Oslo, Norway
Sonia Hernandez-Diaz, MD, DrPH | Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA
Brian T. Bateman, MD, MSc | Stanford University School of Medicine, Stanford, California, USA
Krista F. Huybrechts, MS, PhD | Harvard Medical School, Boston, Massachusetts, USA
Clinical Collaborators
Our research benefits from the input from our diverse team of clinical collaborators.
Matthew Kronman, MD, MSCE | Seattle Children's Hospital, Seattle, Washington, USA
Malavika Prabhu, MD | Massachusetts General Hospital, Boston, Massachusetts, USA
Katherine Wisner, MD | Northwestern University, Evanston, Illinois, USA
Christopher McDougle, MD | Massachusetts General Hospital, Boston, Massachusetts, USA
Kathryn Gray, MD, PhD | University of Washington, Seattle, Washington, USA
Barry Lester, PhD | Brown University, Providence, Rhode Island, USA
Mishka Terplan, MD, MPH | Friends Research Institute, Baltimore, Maryland, USA
Jonathan Davis, MD | Tufts Medical Center, Boston, Massachusetts, USA
Hilary Connery, MD PhD | McLean Hospital, Boston, Massachusetts, USA
Ellen Seely, MD | Brigham and Women's Hospital, Boston, Massachusetts, USA
Page Pennell, MD | Brigham and Women's Hospital, Boston, Massachusetts, USA
Lee Cohen, MD | Massachusetts General Hospital, Boston, Massachusetts, USA
Thomas McElrath, MD, PhD | Brigham and Women's Hospital, Boston, Massachusetts, USA
Lewis Holmes, MD | Massachusetts General Hospital, Boston, Massachusetts, USA
Leslie Kerzner, MD | Massachusetts General Hospital, Boston, Massachusetts, USA
Vaccines and Medications in Pregnancy Surveillance System (VAMPSS)
VAMPSS is a national surveillance system designed to monitor the use and safety of vaccines and medications during pregnancy, and uses three data collection approaches to get information about how vaccines and medications might affect your baby. One part of the study collects information from women while they are pregnant and up to one year after their baby is born, the other recruits certain women who have infants born with congenital malformations (birth defects) and others whose infants are born without malformations, and the third uses large administrative databases to assess medication safety in pregnancy.
VAMPSS is a collaboration of the AAAAI, the Organization of Teratology Information Specialists (OTIS) Research Center at the University of California San Diego, the Slone Epidemiology Center (SEC) at Boston University and Harvard Program in Perinatal and Pediatric Pharmacoepidemiology (H4P). VAMPSS activities are coordinated by an independent advisory committee comprised of individuals from the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Congress of Obstetrics and Gynecology (ACOG) and the American Academy of Pediatrics (AAP) as well as an independent biostatistician and a consumer representative.
VAMPSS is a collaboration of the AAAAI, the Organization of Teratology Information Specialists (OTIS) Research Center at the University of California San Diego, the Slone Epidemiology Center (SEC) at Boston University and Harvard Program in Perinatal and Pediatric Pharmacoepidemiology (H4P). VAMPSS activities are coordinated by an independent advisory committee comprised of individuals from the Centers for Disease Control and Prevention (CDC), National Institutes of Health (NIH), American Congress of Obstetrics and Gynecology (ACOG) and the American Academy of Pediatrics (AAP) as well as an independent biostatistician and a consumer representative.
